Detects GDF‑8/Myostatin Propeptide in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross‑reactivity with mature recombinant mouse (rm) GDF-8 is observed and less than 5% cross-reactivity with mature rmGDF-1, -3, -5, -6, -7, -9, and recombinant human GDF-11 is observed.
Measured by its ability to neutralize GDF‑8 Propeptide inhibition of GDF‑8/Myostatin-dependent hemoglobin expression in the K562 human chronic myelogenous leukemia cell line. The Neutralization Dose (ND50) is typically 10-30 µg/mL in the presence of 800 ng/mL Recombinant Mouse GDF‑8 Propeptide and 40 ng/mL Recombinant Mouse GDF‑8/Myostatin.
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
GDF‑8 Propeptide Inhibition of GDF‑8/Myostatin-induced Hemoglobin Expression and Neutralization by Mouse GDF‑8 Propeptide Antibody. Recombinant Mouse GDF‑8 Propeptide (Catalog # 1539‑PG) inhibits Recombinant Mouse GDF‑8/Myostatin (Catalog # 788‑G8) induced hemoglobin expression in the K562 human chronic myelogenous leukemia cell line in a dose-dependent manner (orange line), as measured by the psuedoperoxidase assay. Inhibition of Recombinant Mouse GDF‑8/Myostatin (40 ng/mL) activity elicited by Recombinant Mouse GDF‑8 Propeptide (800 ng/mL) is neutralized (green line) by increasing concentrations of Sheep Anti-Mouse GDF‑8/Myostatin Propeptide Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1539). The ND50 is typically 10-30 µg/mL.
Preparation and Storage
Reconstitute at 0.2 mg/mL in sterile PBS.
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Growth Differentiation Factor 8 (GDF-8), also known as Myostatin, is a secreted TGF-beta superfamily protein that is expressed specifically in developing and adult skeletal muscle. It controls myoblast proliferation and is a potent negative regulator of skeletal muscle mass (1‑3). Mouse GDF-8 is synthesized as a 376 amino acid (aa) preproprotein that consists of a 24 aa signal peptide, a 243 aa propeptide, and a 109 aa mature protein (2). Within the propeptide, mouse GDF-8 shares 96% and 99% aa sequence identity with human and rat GDF-8, respectively. GDF-8 is secreted as a preproprotein that is cleaved by BMP-1 family proteases to separate the 35‑40 kDa propeptide from the 12 kDa bioactive mature protein (4‑6). This results in a latent complex containing a disulfide-linked dimer of the mature protein and two noncovalently-associated molecules of the propeptide (2, 6). The GDF-8 propeptide functions as an inhibitor of mature GDF-8, and GDF-8 activity can also be inhibited through association with Follistatin, FLRG, Decorin, or GASP-1 (6‑11). The uncleaved GDF-8 proprotein binds Latent TGF-beta bp3 which can sequester it in the extracellular matrix and prevent the proteolytic cleavage of the propeptide (12). GDF-8 binds to the type II Activin receptor Activin RIIB which then associates with the type I receptors Activin RIB/ALK-4 or TGF-beta RI/ALK-5 to induce signaling (13). GDF-8 additionally inhibits adipogenic differentiation of mesenchymal stem cells and preadipocytes (14). Genetic deletion of GDF-8 or in vivo administration of the GDF-8 propeptide induces muscle hypertrophy as well as enhanced glucose utilization and insulin sensitivity and a reduction in overall fat mass (15, 16).
McPherron, A.C. (2010) Immunol. Endocr. Metab. Agents Med. Chem. 10:217.
McPherron, A.C. et al. (1997) Nature 387:83.
Zimmers, T.A. et al. (2002) Science 296:1486.
Wolfman, N.M. et al. (2003) Proc. Natl. Acad. Sci. 100:15842.
McFarlane, C. et al. (2005) Dev. Biol. 283:58.
Lee, S.J. et al. (2001) Proc. Natl. Acad. Sci. 98:9306.
Thies, R.S. et al. (2001) Growth Factors 18:251.
Amthor, H. et al. (2004) Dev. Biol. 270:19.
Hill, J.J. et al. (2002) J. Biol. Chem. 277:40735.
Miura, T. et al. (2006) Biochem. Biophys. Res. Commun. 340:675.
Hill, J.J. et al. (2003) Molecular Endocrinology 17:1144.
Anderson, S.B. et al. (2008) J. Biol. Chem. 283:7027.
Rebbapragada, A. et al. (2003) Mol. Cell. Biol. 23:7230.
Guo, W. et al. (2008) J. Biol. Chem. 283:9136.
Matsakas, A. et al. (2009) Neuromuscul. Disord. 19:489.
R&D Systems personnel manually curate a database that contains references using R&D Systems products.
The data collected includes not only links to publications in PubMed,
but also provides information about sample types, species, and experimental conditions.
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.